Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
35 USD | -0.78% |
|
+3.63% | -12.54% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.54% | 2.33B | |
+47.38% | 57.87B | |
+40.68% | 40.25B | |
-6.94% | 39.94B | |
-5.16% | 28.54B | |
+11.40% | 26.4B | |
-20.96% | 19.33B | |
+29.87% | 12.4B | |
-0.71% | 12.23B | |
+24.06% | 12.2B |
- Stock Market
- Equities
- CLDX Stock
- News Celldex Therapeutics, Inc.
- Celldex Therapeutics Says Patient Enrollment Completed in Chronic Inducible Urticaria Treatment Study; Shares Rise